Our online tirzepatide medical weight-loss program offers convenient access to wellness support, personalized treatment plans, and direct-to-door medication delivery designed around your long-term wellness goals
Novo Nordisk acquired Emisphere for $1.3 billion in 2020
When paired with regular exercise and a calorie-controlled diet, oral Tirzepatide can deliver remarkable results
The idea is to introduce the medication at a sub-therapeutic level to gauge individual tolerance before committing to the full weight loss dosing schedule
Common side effects of tirzepatide include nausea, diarrhea, and mild gastrointestinal discomfort, which often improve over time
The medication absorbs through the mucous membrane under the tongue directly into the sublingual vein, which drains into the internal jugular vein and then into systemic circulation